FNFDCM
CDMO

Folger Nolan Fleming Douglas Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,429
Closed -$6K – 167
2017
Q2 		$6K Buy
+1,429
New +$5.85K ﹤0.01% 166

Other funds holding CDMO

TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's CDMO Position: Q3 2017 in Review

Folger Nolan Fleming Douglas Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2017, closing a stake of 1,429 shares — an estimated $6K sold.

Folger Nolan Fleming Douglas Capital Management first reported a position in CDMO in Q2 2017 and held it in 1 quarter. The position peaked at $6K in Q2 2017. 53 funds tracked by Wall St. Rank hold CDMO as of Q3 2017.

  • Folger Nolan Fleming Douglas Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Folger Nolan Fleming Douglas Capital Management sold 1,429 Avid Bioservices, Inc. Common Stock shares in Q3 2017, an estimated $6K.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Folger Nolan Fleming Douglas Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $6K in Q2 2017.
  • 53 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2017.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.